House committee approves biodefense measure
The House Energy and Commerce Committee on Wednesday passed legislation to promote countermeasures to bioterrorism and other public health threats.
The Biodefense and Pandemic Vaccine and Drug Development Act of 2006 (H.R. 5533), expands on Project BioShield, which was signed into law two years ago.
The bill establishes a point of authority in the federal government -- the Biomedical Advanced Research and Development Authority -- to coordinate and facilitate efforts to develop countermeasures for bioterrorism or pandemic infectious diseases.
The legislation, which passed on voice vote, also authorizes $160 million in fiscal 2007 and fiscal 2008 for advanced research and development.
Rep. Anna Eshoo, D-Calif., who co-sponsored the legislation with Rep. Mike Rogers, R-Mich., cited the threat of avian influenza or another anthrax attack as reasons for the bill's passage.
House Energy and Commerce Health Subcommittee Chairman Nathan Deal, R-Ga., offered a substitute amendment that made technical changes to the bill. The manager's amendment also passed by voice vote.
RELATED STORIES
- Lawmakers press improvements to Project Bioshield 06/07/06
- National Institutes of Health feels budget squeeze 04/14/06
- Vaccine treatment centers for military personnel partially funded 01/10/06
- Senate panel backs bill to create biodefense agency 10/19/05
- Homeland Security doles out research money 03/02/05
Post a Comment
To post a comment, you must provide a name and a valid e-mail address. Messages must be limited to 400 words. By using this Service you agree not to post material that is obscene, harassing, defamatory, or otherwise objectionable. Although Government Executive does not monitor comments posted to this site (and has no obligation to), it reserves the right to delete, edit, or move any material that it deems to be in violation of this rule.